Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34cdc2-related PITSLRE protein kinases

被引:63
作者
Ariza, ME
Broome-Powell, M
Lahti, JM
Kidd, VJ
Nelson, MA
机构
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA
[3] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38101 USA
关键词
D O I
10.1074/jbc.274.40.28505
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Cdc2L locus encoding the PITSLRE protein kinases maps to chromosome band 1p36 and consists of two duplicated and tandemly linked genes, The purpose of the present study was to determine whether diminution of PITSLRE kinases leads to deregulation of apoptosis. The human melanoma cell lines A375 (Cdc2L wild-type alleles) and UACC 1227 (mutant Cdc2L alleles) were tested with agonist anti-Fas monoclonal antibody. We found that exposure of these cells to anti-Fas for 24, 48, or 72 h resulted in differential sensitivity to Fas-induced apoptosis, In A375, cell death started at 24-48 h post-treatment, and it was maximal by 72 h. Conversely, UACC 1227 cells were resistant to Fas-mediated apoptosis. Induction of PITSLRE histone H1 kinase activity was observed in A375 anti-Fas treated but not in UACC 1227 cells. Also, the PITSLRE protein kinase activity in A375 anti-Fas-treated cells preceded maximal levels of apoptosis. Finally, fluorescence confocal microscopy revealed a nuclear localization of PITSLRE proteins in normal melanocytes and A375 cells but a cytoplasmic localization in UACC 1227 cells. The differences in PITSLRE protein and cellular localization between A375 and UACC 1227 cells appear to account for the differences in sensitivity of the two cells lines to anti-Fas and staurosporine. These observations suggest that alterations in PITSLRE gene expression and protein localization may result in the loss of apoptotic signaling.
引用
收藏
页码:28505 / 28513
页数:9
相关论文
共 39 条
  • [1] INDUCTION OF A COMMON PATHWAY OF APOPTOSIS BY STAUROSPORINE
    BERTRAND, R
    SOLARY, E
    OCONNOR, P
    KOHN, KW
    POMMIER, Y
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 211 (02) : 314 - 321
  • [2] Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor
    Beyaert, R
    Kidd, VJ
    Cornelis, S
    VandeCraen, M
    Denecker, G
    Lahti, JM
    Gururajan, R
    Vandenabeele, P
    Fiers, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) : 11694 - 11697
  • [3] Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
    Boldin, MP
    Goncharov, TM
    Goltsev, YV
    Wallach, D
    [J]. CELL, 1996, 85 (06) : 803 - 815
  • [4] INCREASED EXPRESSION OF A 58-KDA PROTEIN-KINASE LEADS TO CHANGES IN THE CHO CELL-CYCLE
    BUNNELL, BA
    HEATH, LS
    ADAMS, DE
    LAHTI, JM
    KIDD, VJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) : 7467 - 7471
  • [5] Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573
  • [6] Debatin KM, 1996, CELL DEATH DIFFER, V3, P185
  • [7] DRUG-TARGET INTERACTIONS - ONLY THE 1ST STEP IN THE COMMITMENT TO A PROGRAMMED CELL-DEATH
    DIVE, C
    HICKMAN, JA
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (01) : 192 - 196
  • [8] Fiers W, 1996, J INFLAMM, V47, P67
  • [9] Fulda S, 1997, CANCER RES, V57, P3823
  • [10] Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
    Hahne, M
    Rimoldi, D
    Schroter, M
    Romero, P
    Schreier, M
    French, LE
    Schneider, P
    Bornand, T
    Fontana, A
    Lienard, D
    Cerottini, JC
    Tschopp, J
    [J]. SCIENCE, 1996, 274 (5291) : 1363 - 1366